Novartis India Limited (NSE:NOVARTIND)
India · Delayed Price · Currency is INR 1,690.00
-11.90 (-0.70%)
Jul 22, 2026, 3:30 PM IST
Novartis India Market Cap
Novartis India has a market cap or net worth of 41.95 billion as of July 22, 2026. Its market cap has increased by 59.37% in one year.
Market Cap
41.95B
Enterprise Value
35.31B
Revenue
3.54B
Ranking
n/a
PE Ratio
45.02
Stock Price
1,690.00
ChartMarket Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 41.95B, an increase of 233.33%. That is a compound annual growth rate of 4.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 41.95B | 118.11% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 73.83B |
| Aarti Pharmalabs | 63.27B |
| Innova Captab | 55.69B |
| Orchid Pharma | 53.08B |
| RPG Life Sciences | 49.90B |
| Solara Active Pharma Sciences | 27.47B |
| Beta Drugs | 24.62B |
| Indoco Remedies | 22.57B |